17,520 resources
By Version
By Realm
Start Prev Rows 8800 - 9000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.fhir.us.mcode | R4 | mcode-cancer-body-location-vs | Cancer Body Location Value Set | active | 4 | cic | 2025-02 | us | sct tho |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.80 | Pregnancy Status Determination Method | active | 2024-06 | us | sct | ||
hl7.fhir.us.mcode | R4 | mcode-brachytherapy-modality-vs | Brachytherapy Modality Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-radiotherapy-modality-vs | Radiotherapy Modality Value Set | active | 3 | cic | 2025-02 | us | fhir tho |
hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-modality-vs | Teleradiotherapy Modality Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.uv.termchangeset | R4 | defining-relationship-type-vs | Defining Relationship Type Value Set | draft | 0 | vocab | 2025-07 | uv | sct |
hl7.fhir.uv.termchangeset | R4 | el-profile-set-operator-vs | EL Profile Set Operator Value Set | draft | 0 | vocab | 2025-07 | uv | sct |
hl7.fhir.us.davinci-dtr | R4 | informationOrigins | Information Origins Value Set | trial-use | 2 | cds | 2025-07 | us | fhir |
hl7.terminology | R5 | communication-topic | CommunicationTopic | active | 1 | pc | 2024-04 | uv | tho |
hl7.terminology | R5 | history-absent-reason | FamilyHistoryAbsentReason | active | 1 | pc | 2024-04 | uv | tho |
hl7.fhir.us.mcode | R4 | mcode-brachytherapy-technique-vs | Brachytherapy Technique Value Set | active | 3 | cic | 2025-02 | us | fhir |
hl7.fhir.us.mcode | R4 | mcode-radiotherapy-technique-vs | Radiotherapy Technique Value Set | active | 3 | cic | 2025-02 | us | fhir tho |
hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-technique-vs | Teleradiotherapy Technique Value Set | active | 3 | cic | 2025-02 | us | fhir |
hl7.fhir.us.mcode | R4 | mcode-radiotherapy-volume-type-vs | Radiotherapy Volume Type Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.pacio-rt | R4 | timepoint-entity-type-vs | Timepoint Entity Type Value Set | active | 2022-10 | us | fhir | ||
hl7.fhir.us.identity-matching | R4 | Identity-Identifier-vs | Identity Identifier Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.cz.core | R4 | cz-specimentype-vs | Specimen Type | draft | 2025-07 | cz | sct | ||
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | m11-country-region-vs | Study Amendment Country Value Set | informative | brr | 2025-07 | uv | fhir | |
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | nci-study-role-vs | NCI Study Role Value Set | informative | brr | 2025-07 | uv | ncit | |
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | m11-study-amendment-reason-vs | Study Amendment Reaason Value Set | informative | brr | 2025-07 | uv | ncit | |
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | m11-study-amendment-scope-vs | Study Amendment Scope Value Set | informative | brr | 2025-07 | uv | ncit | |
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | ddf-study-title-type-vs | CDISC DDF Study Title Type Value Set | informative | brr | 2025-07 | uv | ncit | |
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | m11-phase-vs | M11 Phase Value Set | informative | brr | 2025-07 | uv | ncit | |
hl7.fhir.uv.saner | R4 | Covid19Labs | COVID-19 Diagnostic Test | active | pher | 2024-05 | uv | fhir loinc | |
hl7.fhir.us.physical-activity | R4 | pa-condition-verification-status | PA Condition Verification Status | trial-use | 2 | pc | 2024-03 | us | tho |
hl7.fhir.us.physical-activity | R4 | pa-diagnosticreport-status | PA DiagnosticReport Statuses | trial-use | 2 | pc | 2024-03 | us | fhir |
hl7.fhir.us.ndh | R4 | HealthcareServiceEligibilityCodeVS | Healthcare Service Eligibility Code Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.directory-query | R4 | IdentifierStatusVS | Identifier Status Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.ndh | R4 | IdentifierStatusVS | Identifier Status Value Set | trial-use | pa | 2025-07 | us | tho | |
hl7.fhir.us.ndh | R4 | BenefitTypeVS | Benefit Type Value Set | trial-use | pa | 2025-07 | us | tho | |
hl7.fhir.us.ndh | R4 | NDHCareTeamCategoryVS | NDH Care Team Category Value Set | trial-use | pa | 2025-07 | us | loinc | |
hl7.fhir.us.ndh | R4 | NdhEndpointEnvironmentVS | NDH Endpoint Environment Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.physical-activity | R4 | pa-observation-status | PA Observation Statuses | trial-use | 2 | pc | 2024-03 | us | fhir |
hl7.fhir.us.physical-activity | R4 | pa-observation-code-evs | PA Observation Vital Sign Codes | trial-use | 2 | pc | 2024-03 | us | loinc |
hl7.fhir.us.physical-activity | R4 | pa-servicerequest-intent | PA ServiceRequest Intents | trial-use | 2 | pc | 2024-03 | us | fhir |
hl7.fhir.uv.saner | R4 | NegativeResults | COVID-19 Not Detected | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | PositiveResults | COVID-19 Detected | active | pher | 2024-05 | uv | sct | |
fhir.giis | R4 | AEFISeverityVS | Adverse Event severity codes | draft | 2025-07 | us | internal | ||
fhir.giis | R4 | AEFINameVS | Adverse Event codes | draft | 2025-07 | us | internal | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-assessment-scales | Assessment Scales | draft | 2023-10 | uv | sct loinc | ||
signal.core.r4 | R4 | birthsex | Birth Sex | active | 2022-09 | us | vsac | ||
hl7.cql | R4 | cql-message-category | CQL Message Category | trial-use | 2 | cds | 2025-07 | internal | |
hl7.fhir.us.davinci-pct | R4 | PCTTaskBusinessStatusCodes | PCT GFE Request Task Business Status ValueSet | trial-use | fm | 2025-06 | us | fhir | |
hl7.fhir.us.ndh | R4 | EndpointAccessControlMechanismVS | Endpoint Access Control Mechanism Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.ndh | R4 | AgeGroupVS | Age Range Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.directory-query | R4 | EndpointUsecaseVS | Endpoint Usecases Value Set | active | 2022-12 | us | tho | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointUsecaseVS | Endpoint Usecases VS | trial-use | fm | 2025-02 | us | tho | |
hl7.fhir.us.ndh | R4 | NdhDirectTrustEndpointUsecaseVS | NDH Direct Trust Endpoint Usecase Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.ndh | R4 | NdhFhirEndpointUseCaseVS | NDH FHIR Endpoint Usecase Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.uv.vhdir | R4 | usecasetype | VhDir Use Case Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.us.directory-query | R4 | DeliveryMethodVS | Delivery Methods Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | DeliveryMethodVS | Delivery Methods VS | trial-use | fm | 2025-02 | us | fhir | |
hl7.fhir.us.ndh | R4 | EmploymentStatusVS | Employment Status Value Set | trial-use | pa | 2025-07 | us | tho | |
hl7.fhir.us.ndh | R4 | AccessibilityVS | Accessibility Value Set | trial-use | pa | 2025-07 | us | tho | |
hl7.fhir.us.directory-query | R4 | AccessibilityVS | Accessibility Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | AccessibilityVS | Accessibility VS | trial-use | fm | 2025-02 | us | fhir | |
hl7.fhir.uv.vhdir | R4 | accessibility | VhDir Accessibility Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.us.ndh | R4 | InsuranceStatusVS | Insurance Status Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.uv.vhdir | R4 | network-type | VhDir Network Type Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | patientaccess | VhDir Ehr Patient Access Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | identifier-type | VhDir Identifier Type Value Set | trial-use | 2 | pa | 2018-02 | uv | tho |
hl7.fhir.ca.baseline | R4 | birthsex | Birth Sex | draft | 2019-03 | ca | tho | ||
hl7.fhir.us.directory-query | R4 | LanguageProficiencyVS | Language Proficiency Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | LanguageProficiencyVS | Language Proficiency VS | trial-use | fm | 2025-02 | us | fhir | |
hl7.fhir.uv.vhdir | R4 | languageproficiency | VhDir Spoken Language Proficiency | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.us.ndh | R4 | EndpointTestingMethodVS | Endpoint Testing Method Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.uv.vhdir | R4 | certificationedition | VhDir Certification Edition Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | aliastype | VhDir Alias Type Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | qualificationstatus | VhDir Qualification Status | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | identifierstatus | VhDir Identifier Status Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.us.ndh | R4 | TrustProfileVS | Trust Profile Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.ndh | R4 | VerificationProcessVS | NDH Verification Process Value Set | trial-use | pa | 2025-07 | us | tho | |
hl7.fhir.us.icsr-ae-reporting | R4 | ICSRSectionCodeVS | ICSR Section Codes Value Set | draft | 2023-08 | us | fhir | ||
hl7.terminology | R5 | communication-category | CommunicationCategory | active | 1 | pc | 2024-04 | uv | tho |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetObservationDerivedFromIdType | SDOHCC ValueSet Observation DerivedFrom IdType | trial-use | 2 | pc | 2025-05 | us | tho |
hl7.cql | R4 | cql-message-code | CQL Message Code | trial-use | 2 | cds | 2025-07 | internal | |
hl7.fhir.us.davinci-crd | R4 | coverageDetail | CRD Coverage Detail Codes Value Set | trial-use | 4 | fm | 2025-07 | us | fhir |
hl7.fhir.us.davinci-crd | R4 | deviceRequest | CRD Device Request Codes Value Set | trial-use | 4 | fm | 2025-07 | us | cpt cms |
hl7.fhir.us.physical-activity | R4 | pa-observation-code-time | PA Observation Time-related codes | trial-use | 2 | pc | 2024-03 | us | loinc |
hl7.fhir.uv.recon-ig | R5 | apix-provenance-activity | APIX Provenance Activity Value Set | draft | 2025-07 | uv | |||
hl7.fhir.uv.recon-ig | R5 | apix-document-type | APIX Document Type Value Set | draft | 2025-07 | uv | loinc | ||
hl7.fhir.uv.recon-ig | R5 | apix-task-code | APIX Task Code Value Set | draft | 2025-07 | uv | |||
hl7.cql | R4 | cql-message-severity | CQL Message Severity | trial-use | 2 | cds | 2025-07 | internal | |
hl7.fhir.us.ndh | R4 | DigitalcertificateUseVS | Digital Certificate Use Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.davinci-pct | R4 | PCTGFERequestTypeVS | PCT GFE Request Type Codes ValueSet | trial-use | fm | 2025-06 | us | fhir | |
hl7.terminology | R5 | adverse-event-causality-assess | AdverseEventCausalityAssessment | active | 1 | pc | 2024-04 | uv | tho |
hl7.fhir.us.ndh | R4 | PractitionerRoleVS | PractitionerRole Code Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.directory-query | R4 | PractitionerRoleVS | PractitionerRole Code Value Set | active | 2022-12 | us | fhir tho | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | PractitionerRoleVS | PractitionerRole Code VS | trial-use | fm | 2025-02 | us | fhir tho | |
ch.fhir.ig.ch-term | R4 | servicerequest-category | ServiceRequest Category | active | 2025-05 | ch | internal | ||
hl7.fhir.us.davinci-pct | R4 | PCTOrgContactPurposeTypeVS | PCT Organization Contact Purpose Value Set | trial-use | fm | 2025-06 | us | fhir tho | |
hl7.fhir.us.pacio-cs | R4 | pacio-cat-vs | PACIO Functioning Category Value Set | active | 2024-11 | us | fhir | ||
hl7.fhir.us.pacio-fs | R4 | pacio-cat-vs | PACIO Functioning Category Value Set | active | 2021-11 | us | fhir | ||
hl7.fhir.us.pacio-rt | R4 | timepoint-class-vs | Timepoint Class Value Set | active | 2022-10 | us | fhir tho | ||
hl7.fhir.us.davinci-pct | R4 | PCTSubjectToMedicalMgmtReasonVS | PCT Subject-To-Medical-Management Reason Value Set | trial-use | fm | 2025-06 | us | fhir | |
hl7.fhir.us.pacio-rt | R4 | timepoint-status-vs | Timepoint Status Value Set | active | 2022-10 | us | fhir | ||
ch.fhir.ig.ch-term | R4 | mainguarantor | Main Guarantor | active | 2025-05 | ch | |||
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetOMBEthnicityCategories | SDOHCC ValueSet OMB Ethnicity Categories | trial-use | 2 | pc | 2025-05 | us | oid |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetOMBRaceCategories | SDOHCC ValueSet OMB Race Categories | trial-use | 2 | pc | 2025-05 | us | oid |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetTaskCode | SDOHCC ValueSet Task Code | trial-use | 2 | pc | 2025-05 | us | fhir |
hl7.terminology | R5 | research-study-objective-type | ResearchStudyObjectiveType | draft | brr | 2020-02 | uv | tho | |
hl7.terminology | R5 | research-study-prim-purp-type | ResearchStudyPrimaryPurposeType | draft | 0 | brr | 2020-02 | uv | tho |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetPronounsValue | SDOHCC ValueSet Pronouns Value | trial-use | 2 | pc | 2025-05 | us | tho loinc |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetTaskPriority | SDOHCC ValueSet Task Priority | trial-use | 2 | pc | 2025-05 | us | fhir |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetObservationDataAbsentReason | SDOHCC ValueSet Observation DataAbsentReason | trial-use | 2 | pc | 2025-05 | us | tho |
hl7.terminology | R5 | communication-not-done-reason | CommunicationNotDoneReason | active | 1 | pc | 2024-04 | uv | tho |
hl7.terminology | R5 | v3-HumanLanguage | HumanLanguage | retired | 2024-06 | uv | tho | ||
hl7.cql | R4 | cql-message-source | CQL Message Source | trial-use | 2 | cds | 2025-07 | internal | |
hl7.terminology | R5 | research-study-phase | ResearchStudyPhase | draft | 1 | brr | 2020-02 | uv | tho |
hl7.fhir.uv.extensions | R5 | research-study-registration-activity | ResearchStudyRegistrationActivity | trial-use | 2 | brr | 2022-02 | uv | fhir |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetReferralTaskStatus | SDOHCC ValueSet Referral Task Status | trial-use | 2 | pc | 2025-05 | us | fhir |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetObservationStatus | SDOHCC ValueSet Observation Status | trial-use | 2 | pc | 2025-05 | us | fhir |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetTaskStatus | SDOHCC ValueSet Task Status | trial-use | 2 | pc | 2025-05 | us | fhir |
hl7.fhir.us.physical-activity | R4 | pa-diagnosticreport-type | PA DiagnosticReport Types | trial-use | 2 | pc | 2024-03 | us | fhir loinc |
hl7.fhir.us.physical-activity | R4 | pa-servicerequest-code | PA ServiceRequest Intervention Codes | trial-use | 2 | pc | 2024-03 | us | sct |
hl7.fhir.uv.recon-ig | R5 | apix-submission-type | APIX Submission Type Value Set | draft | 2025-07 | uv | |||
hl7.fhir.uv.vhdir | R4 | consent | VhDir Consent Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir tho |
hl7.fhir.us.directory-query | R4 | ConsentVS | National Directory Consent Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.directory-attestation | R4 | ConsentVS | NatDir Consent Scopes Valueset | active | 2022-12 | us | fhir | ||
hl7.fhir.uv.ebm | R6 | research-study-document-types | Research Study Document Types Value Set | trial-use | 1 | cds | 2025-07 | uv | fhir |
hl7.fhir.uv.ebm | R6 | search-strategy-characteristic | Search Strategy Characteristic Value Set | trial-use | 1 | cds | 2025-07 | uv | fhir |
hl7.terminology | R5 | mif-conceptRelationshipReflexivity | MIF Concept Relationship Reflexivity | draft | 2025-07 | uv | tho | ||
hl7.terminology | R5 | mif-conceptRelationshipKind | MIF Concept Relationship Kind | draft | 2025-07 | uv | tho | ||
hl7.terminology | R5 | mif-conceptRelationshipSymmetry | MIF Concept Relationship Symmetry | draft | 2025-07 | uv | tho | ||
hl7.terminology | R5 | mif-conceptRelationshipTransitivity | MIF Concept Relationship Transitivity | draft | 2025-07 | uv | tho | ||
hl7.fhir.be.mycarenet | R4 | eagreementadjudicationreason | ValueSet adjudication reason | trial-use | 1 | fhir | 2025-06 | be | internal |
hl7.fhir.be.terminology | R4 | eagreementadjudicationreason | ValueSet adjudication reason | trial-use | 1 | fhir | 2025-02 | be | internal |
hl7.fhir.be.mycarenet | R4 | eagreementmessage | ValueSet message | trial-use | 1 | fhir | 2025-06 | be | internal fhir |
hl7.fhir.be.terminology | R4 | eagreementmessage | ValueSet message | trial-use | 1 | fhir | 2025-02 | be | internal fhir |
hl7.fhir.uv.ebm | R6 | recommendation-justification-classifier | Recommendation Justification Classifier Codes Value Set | trial-use | 1 | cds | 2025-07 | uv | |
hl7.fhir.uv.ebm | R6 | evidence-rating-system-classifier | Evidence Rating System Classifier Codes Value Set | trial-use | 1 | cds | 2025-07 | uv | fhir |
hl7.fhir.us.ndh | R4 | NdhVerificationStatusVS | NDH Verification Status Value Set | trial-use | pa | 2025-07 | us | fhir | |
hl7.fhir.us.ndh | R4 | VirtualModalitiesVS | Virtual Modalities Value Set | trial-use | pa | 2025-07 | us | tho | |
hl7.fhir.us.directory-query | R4 | VirtualModalitiesVS | Virtual Modalities Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | VirtualModalitiesVS | Virtual Modalities VS | trial-use | fm | 2025-02 | us | fhir | |
hl7.terminology | R5 | research-study-reason-stopped | ResearchStudyReasonStopped | draft | 1 | brr | 2020-02 | uv | tho |
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-certainty-of-evidence | Rating Certainty Of Evidence | draft | 2022-09 | uv | fhir | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-concern-degree | Rating Concern Degree | draft | 2022-09 | uv | fhir | ||
hl7.fhir.us.spl | R5 | valueset-splColor | SPL Color | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splComboProductType | SPL Combo Product Type | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splDoseForm | SPL Dose Form | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splFlavor | SPL Flavor | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splMarketingCategories | SPL Marketing Categories | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splOperationType | SPL Operation Type | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splPackageTypes | SPL Package Types | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splRouteOfAdministration | SPL Route of Administration | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splShape | SPL Shape | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.fhir.us.spl | R5 | valueset-splSpecialMeasures | SPL Special Measures | trial-use | 1 | brr | 2025-07 | us | ncit |
hl7.eu.fhir.idea4rc | R4 | coded-test-results-athena-vs | Coded test results: Athena. | draft | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | cancer-histology-behavior-athena-vs | Cancer histology behaviour: Athena | draft | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | cancer-histology-subgroup-athena-vs | Cancer histology subgroup: Athena | draft | 2025-07 | eu | internal | ||
hl7.fhir.uv.saner | R4 | AllCOVID19RiskFactors | All COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | COPDCOVID19RiskFactors | COPD COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | CardiovascularCOVID19RiskFactors | Cardiovascular COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | KidneyDiseaseCOVID19RiskFactors | Kidney Disease COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | DiabetesCOVID19RiskFactors | Diabetes COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | HypertensionCOVID19RiskFactors | Hypertension COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | NeoplasticCOVID19RiskFactors | Neoplastic COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | ObesityCOVID19RiskFactors | Obesity COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | PregnancyCOVID19RiskFactors | Pregnancy COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | SickleCellCOVID19RiskFactors | Sickle Cell COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | TobaccoCOVID19RiskFactors | Tobacco COVID-19 Risk Factors | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | COVID19Complications | COVID-19 Complications | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | VTEReports | Codes for reports about VTE Diagnosics | active | pher | 2024-05 | uv | loinc | |
hl7.fhir.uv.saner | R4 | IsolationPrecautions | COVID-19 Isolation Precautions | active | pher | 2024-05 | uv | sct | |
hl7.fhir.us.davinci-crd | R4 | cdsHookType | CDS Hook Types Value Set | trial-use | 4 | fm | 2025-07 | us | fhir |
hl7.terminology | R5 | parameter-group | DeviceDefinitionParameterGroup | draft | oo | 2020-02 | uv | tho | |
hl7.terminology | R5 | v3-NationEntityType | NationEntityType | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.saner | R4 | SuspectedOrConfirmedCOVID19Diagnoses | Suspected Or Diagnosed COVID-19 | active | pher | 2024-05 | uv | sct icd | |
hl7.eu.fhir.idea4rc | R4 | HNC-condition-athena-vs | HNC ConditionList: Athena | draft | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | cancer-diagnosis-athena-vs | Cancer Diagnosis: Athena | draft | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | sarcome-list-athena-vs | Sarcome List: Athena | draft | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | cancer-histology-athena-vs | Cancer histology: Athena | draft | 2025-07 | eu | internal | ||
signal.core.r4 | R4 | chargeitem-status | ChargeItemStatus | trial-use | 0 | pa | 2019-10 | us | fhir |
hl7.terminology | R5 | definition-status | DefinitionStatus | draft | fhir | 2020-02 | uv | tho | |
signal.core.r4 | R4 | invoice-status | InvoiceStatus | trial-use | 0 | fm | 2019-10 | us | fhir |
hl7.fhir.uv.ae-research-backport-ig | R4 | adverse-event-status-vs | Adverse Event Status | informative | brr | 2024-04 | uv | fhir | |
signal.core.r4 | R4 | event-status | EventStatus | trial-use | 3 | fhir | 2019-10 | us | fhir |
signal.core.r4 | R4 | request-status | RequestStatus | draft | 3 | pc | 2019-10 | us | fhir |
hl7.eu.fhir.idea4rc | R4 | cancer-event-type-vs | Disease Status: Athena | draft | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | metastasis-disorder-athena-vs | Metastatis: Athena | draft | 2025-07 | eu | |||
hl7.fhir.us.mcode | R4 | mcode-neuroblastoma-inss-value-vs | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set | active | cic | 2025-02 | us | sct | |
hl7.fhir.us.mcode | R4 | mcode-myeloma-iss-stage-value-vs | International Staging System (ISS) for Myeloma Stage Value Set | active | cic | 2025-02 | us | ncit | |
hl7.fhir.us.mcode | R4 | mcode-myeloma-riss-stage-value-vs | Revised International Staging System (ISS) for Multiple Myeloma Stage Value Set | active | cic | 2025-02 | us | ncit | |
hl7.fhir.us.mcode | R4 | mcode-all-risk-assessment-value-vs | Acute Lymphoblastic Leukemia (ALL) Risk Assessment Value Set | active | cic | 2025-02 | us | ncit | |
hl7.fhir.us.mcode | R4 | mcode-binet-stage-value-vs | Binet Stage Value Set | active | cic | 2025-02 | us | ncit | |
hl7.fhir.us.mcode | R4 | mcode-breslow-depth-stage-value-vs | Breslow Depth Stage Value Set | active | cic | 2025-02 | us | sct | |
hl7.fhir.us.mcode | R4 | mcode-neuroblastoma-INRGSS-value-vs | International Neuroblastoma Risk Group Staging System (INRGSS) for Neuroblastoma Risk Assessment Value Set | active | cic | 2025-02 | us | ncit | |
hl7.fhir.us.mcode | R4 | mcode-wilms-tumor-stage-value-vs | Wilms Tumor Stage Value Set | active | cic | 2025-02 | us | sct | |
hl7.fhir.us.mcode | R4 | mcode-pretext-stage-value-vs | PRETEXT Stage Value | active | cic | 2025-02 | us | ncit | |
hl7.fhir.us.mcode | R4 | mcode-rai-stage-value-vs | Rai Stage Value Set | active | cic | 2025-02 | us | ncit | |
hl7.fhir.us.mcode | R4 | mcode-rhabdomyosarcoma-assessment-value-vs | Rhabdomyosarcoma Assessment Value Set | active | cic | 2025-02 | us | ncit sct | |
hl7.fhir.us.mcode | R4 | mcode-international-retinoblastoma-stage-value-vs | International Retinoblastoma Stage Value | active | cic | 2025-02 | us | ncit | |
ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-substance-admin-substitution-code | Substance Administration Substitution Codes | draft | 2025-01 | ch | tho | ||
hl7.fhir.us.pacio-adi | R4 | ADIPMOConsentCategoriesVS | Portable Medical Order Categories | trial-use | 2 | pe | 2025-07 | us | tho |
hl7.fhir.us.pacio-adi | R4 | ADIAttesterRoleTypeVS | Attester Role | trial-use | 2 | pe | 2025-07 | us | loinc |
hl7.fhir.us.physical-activity | R4 | pa-task-status | PA Task Fulfillment Status | trial-use | 2 | pc | 2024-03 | us | fhir |
hl7.fhir.us.pacio-adi | R4 | ADIHCADecisionsVS | Healthcare Agent Decisions | trial-use | 2 | pe | 2025-07 | us | fhir loinc |
hl7.fhir.us.davinci-pct | R4 | PCTAdjustmentReasonVS | PCT Adjustment Reason | trial-use | fm | 2025-06 | us | x12 | |
hl7.fhir.us.illTraveler | R4 | InfectiousDiseaseVS | Infectious Disease VS | draft | 2024-03 | us | sct |